uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
PET with [11C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions
(Uppsala University Pet-Centre)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Radiology, Oncology and Radiation Science, Section of Nuclear Medicine and PET. (Uppsala University Pet-Centre)
(Uppsala University Pet-Centre)
(Uppsala University Pet-Centre)
Show others and affiliations
1999 (English)In: Clinical Positron Imaging, ISSN 1095-0397, Vol. 2, no 6, 339- p.Article in journal (Refereed) Published
Abstract [en]


The purpose of the study was to evaluate the potential role of PET with the adrenocortical-specific tracer 11C-metomidate in the characterization of incidentally found adrenal cortical lesions and in adrenocortical carcinomas.


PET with 11C-metomidate was performed in 15 patients with unilateral adrenal mass confirmed by CT (incidentalomas) and in 9 additional patients with adrenocortical cancer. All incidentalomas subsequently underwent surgery, except 2 subjected to biopsy only. These lesions were histopathologically examined and diagnosed as adrenal cortical adenoma (n = 6; 3 nonfunctioning), adrenocortical carcinoma (n = 2) and nodular hyperplasia (n = 1). The remaining were non-cortical lesions including 1 pheochromocytoma, 1 myelolipoma, 2 adrenal cysts, and 2 metastases.


All lesions, except 1, with an adrenocortical origin were easily identified due to exceedingly high uptake of 11C-metomidate, whereas the non-cortical lesions showed very low uptake. The 1 false negative was a cancer that at surgery was found to be extensively necrotic. High uptake was also seen in normal adrenal glands. The tracer uptake kinetics indicated trapping of the tracer in the cortical lesions. For quantitative evaluation of tracer binding in individual lesions, the simple SUV concept was found to be equally accurate as more elaborate kinetic analyses.


The patients presented and altogether over 40 PET investigations have demonstrated 11C-metomidate to be an attractive tracer for the characterization of adrenal masses with the ability to discriminate lesions of adrenal cortical origin from non-cortical lesions. Additionally the method allows the assessment of metastases from adrenocortical cancers, and the very high contrast has allowed partial whole-body examinations.

Place, publisher, year, edition, pages
1999. Vol. 2, no 6, 339- p.
National Category
Radiology, Nuclear Medicine and Medical Imaging
URN: urn:nbn:se:uu:diva-73654DOI: 10.1016/S1095-0397(99)00099-0PubMedID: 14516636OAI: oai:DiVA.org:uu-73654DiVA: diva2:101564
Available from: 2005-06-13 Created: 2005-06-13 Last updated: 2014-09-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=14516636&dopt=Citation

Search in DiVA

By author/editor
Bergström, MatsSörensen, JensJuhlin, ClaesEriksson, BarbroSundin, AndersLångström, Bengt
By organisation
Section of Nuclear Medicine and PETEndocrine Tumor BiologyRadiology
In the same journal
Clinical Positron Imaging
Radiology, Nuclear Medicine and Medical Imaging

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 237 hits
ReferencesLink to record
Permanent link

Direct link